1. Home
  2. PRO vs SEPN Comparison

PRO vs SEPN Comparison

Compare PRO & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRO
  • SEPN
  • Stock Information
  • Founded
  • PRO 1985
  • SEPN 2022
  • Country
  • PRO United States
  • SEPN United States
  • Employees
  • PRO N/A
  • SEPN N/A
  • Industry
  • PRO EDP Services
  • SEPN
  • Sector
  • PRO Technology
  • SEPN
  • Exchange
  • PRO Nasdaq
  • SEPN NYSE
  • Market Cap
  • PRO 1.1B
  • SEPN 1.0B
  • IPO Year
  • PRO 2007
  • SEPN 2024
  • Fundamental
  • Price
  • PRO $23.62
  • SEPN $21.79
  • Analyst Decision
  • PRO Strong Buy
  • SEPN Strong Buy
  • Analyst Count
  • PRO 8
  • SEPN 4
  • Target Price
  • PRO $31.63
  • SEPN $43.67
  • AVG Volume (30 Days)
  • PRO 620.3K
  • SEPN 346.4K
  • Earning Date
  • PRO 10-29-2024
  • SEPN 11-20-2024
  • Dividend Yield
  • PRO N/A
  • SEPN N/A
  • EPS Growth
  • PRO N/A
  • SEPN N/A
  • EPS
  • PRO N/A
  • SEPN N/A
  • Revenue
  • PRO $322,887,000.00
  • SEPN $981,000.00
  • Revenue This Year
  • PRO $9.81
  • SEPN N/A
  • Revenue Next Year
  • PRO $9.37
  • SEPN N/A
  • P/E Ratio
  • PRO N/A
  • SEPN N/A
  • Revenue Growth
  • PRO 8.66
  • SEPN N/A
  • 52 Week Low
  • PRO $16.64
  • SEPN $18.62
  • 52 Week High
  • PRO $40.99
  • SEPN $26.34
  • Technical
  • Relative Strength Index (RSI)
  • PRO 64.93
  • SEPN N/A
  • Support Level
  • PRO $21.40
  • SEPN N/A
  • Resistance Level
  • PRO $23.69
  • SEPN N/A
  • Average True Range (ATR)
  • PRO 1.01
  • SEPN 0.00
  • MACD
  • PRO 0.00
  • SEPN 0.00
  • Stochastic Oscillator
  • PRO 88.09
  • SEPN 0.00

About PRO PROS Holdings Inc.

Pros Holdings Inc. is a provider of cloud-based revenue and profit realization software solutions to business-to-business and business-to-consumer companies. Its solutions assist customers in growing revenue, modernizing business processes, and supporting profitability by leveraging prescriptive analytics and data science-based decision-making technology. The company's solutions enable buyers to move fluidly across its customers' direct sales, partner, online, mobile, and emerging channels with personalized experiences. The firm generates revenue in the United States, Europe, Africa, Asia-Pacific, and Middle East regions.

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

Share on Social Networks: